Autoimmune hepatitis and anti-Ro antibodies. Is there a link?;Hepatitis autoinmune y anticuerpos anti-Ro positivos. ¿Alguna relación?

Gastroenterologia y Hepatologia

Volumn 26, Issue 8, 2003, Pages 475-479

  Devesa i Jorda F ^a   Ferrando Ginestar, J ^a   Bustamante Balen M ^a   Ortuno Cortes J ^a   Borghol Hariri, A ^a   Ramos Niguez J A ^a   Jimenez Sanchez A ^a   Mery Rams, S ^b   Rull Segura, S ^a  

^a HOSPITAL FRANCESC DE BORJA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; RIBONUCLEOPROTEIN; RO ANTIBODY; RO ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE MARKER; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS; PATHOGENESIS; REVIEW; SJOEGREN SYNDROME;

EID: 0142260438     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051929     Document Type: Review

References (36)

1. Gregorio GV, Davis ET, Mieli-Vergani G, Vergani D. Significance of extractable nuclear antigens in childhood autoimmune liver disease. Clin Exp Immunol 1995;102:308-13.
2. Parveen S, Morshed SA, Arima K, Nishioka M, Czaja AJ, Chow WCh, et al. Antibodies to Ro/La, Cenp-B and snRNPs antigens in autoimmune hepatitis of North America versus Asia. Patterns of immunofluorescence, ELISA reactivities and HLA association. Dig Dis Sci 1998;43:1322-31.
3. Álvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
4. Sherer Y, Shoenfeld Y. The idiotypic network in antinuclearantibody-associated diseases. Int Arch Allergy Immunol 2000; 123:10-5.
5. Clark G, Reichlin M, Tomasi TB. Characteritzacion of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969;102:117-30.
6. Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients. Arthritis Rheum 1974;17:421-9.
7. Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975;55:1067-73.
8. Sibilia J. Ro (SS-A) and anti-Ro (SS-A): an update. Rev Rheum Engl Ed 1998;65:45-57.
9. Scofield RH, Farris AD, Horsfall AC, Harley JB. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum 1999;42:199-209.
10. Zimmermann C, Smolen JS, Graninger W, Petera P, Fabini G, Hassfeld W, et al. Fine Specificity of anti-Ro (SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus. J Rheumatol 1996;23:1897-903.
11. Simmons-O'Brien E, Chen S, Watson R, Antoni C, Petri M, Hochberg M, et al. One hundred anti-Ro (SS-A) antibody positive patients: a 10-year folow-up. Medicine (Baltimore) 1995; 74:109-30.
12. Peek R, Prujin GJM, Van Der Kemp AJW, Van Venrooij WJ. Subcellular distribution of Ro ribonucleoprotein complexes and their constituents. J Cell Sci 1993;106:929-35.
13. Simons FHM, Rutges SA, Vanvenrooij WJ, Prujin GJM. The interactions with Ro 60 and La differentially affect nuclear export of hY1 RNA. RNA 1996;2:264-73.
14. Kelekar A, Saitta MR, Keene JD. Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins. J Clin Invest 1994;93:1637-44.
15. Alexander E, Buyon JP, Provost TT, Guamieri T. Anti-Ro/SSA antibodies in the pathophyisiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 1992;35:176-89.
16. Garcia S, Nascimiento JH, Bonfa E, Levy R, Oliveira SF, Tavares AV, et al. Cellular mechanisms of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest 1994;93:718-24.
17. Kita H, Mackay IR, Van the Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001;120:1485-501.
18. Wolina U, Beensen H, Kittler L, Schaarschmidt H, Knopf B. PUVA treatment of human cultured fibroblasts from psoriatic skin enhances the binding of antibodies to SSA (Ro). Dermatol Res 1987;279:206-8.
19. Zhu J. Cytomegalovirus infection induces expression of 60 kD/Ro antigen on human keratinocytes. Lupus 1995;4:396-406.
20. Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 1988;141:1480-8.
21. Smeenk RJT. RO/SS-A and La/SS-B: Autoantigens in Sjögren's syndrome? Clin Rheumatol 1995;14:11-6.
22. Bouffard P, Laniel MA, Boire G. Anti-Ro (SSA) antibodies: clinical significance and biological relevance. J Rheumatol 1996;23:1838-41.
23. Lee LA, Harmon CE, Huff JC, Norris DA, Weston WL. The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin. J Invest Dermatol 1985;85:143-6.
24. Dorner T, Feis E, Held C, Conrad K, Burmester GR, Hiepe F. Differential recognition of the 52-kD Ro (SS-A) antigen by sera from patients with primary Sjögren's syndrome. Hepatology 1996;24:1404-7.
25. Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann Rheum Dis 1995;54:148-51.
26. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994; 107:200-7.
27. Krawitt EL. Autoimmune hepatitis. N Eng J Med 1996;334: 897-903.
28. Bruguera M, Caballería Ll, Parés A, Rodés J. Hepatitis autoinmune. Características clínicas y respuesta al tratamiento de una serie de 49 pacientes españoles. Gastroenterol Hepatol 1998; 21:375-81.
29. Scofield RH, Harley JB. Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus. Proc Natl Acad Sci 1991;88:3343-7.
30. Scofield RH, Dickey WD, Jackson KW, James JA, Harley JB. A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein. J Clin Immunol 1991;11:378-88.
31. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986;232:1145-7.
32. Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gastroenterology 2001;120:1502-17.
33. Czaja AJ, Homburger HA. Autoantibodies in liver disease. Gastroenterology 2001;120:239-49.
34. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
35. García M, Ramos M, Cervera R, Ingelmo M. Mecanismos inmunopatogénicos de los anticuerpos. En: Font J, García M, Ramos M, Cervera R, Ingelmo M, editores. Autoanticuerpos en la práctica clínica. Barcelona: Masson S.A., 2001; p. 37-50.
36. Mehal WZ, Azzaroli F, Crispe N. Immunology of the healthy liver: old questions and new insigths. Gastroenterology 2001; 120:250-60.